SCHEMBL17499229

SCHEMBL17499229

Cn1ccc(C(=Nc2ccccc2O[SiH](C)C)c2ccccc2)n1

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.41
KMT2A Q03164 4/20 0.32
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
MEN1 O00255 2/20 0.32
TP53 P04637 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
OPRM1 P35372 1/20 0.31
OPRL1 P41146 1/20 0.31
GAA P10253 1/20 0.31
ALDH1A1 P00352 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16101251 0.86 TSHR (0.44) TSHRKMT2ANPC1RAB9AMEN1
SCHEMBL16101714 0.84 TSHR (0.42) TSHRKMT2ANPC1RAB9AMEN1
SCHEMBL17499259 0.84 TSHR (0.36) TSHRKMT2ANPC1RAB9AMEN1
SCHEMBL16098690 0.81 GAA (0.31) RAB9ATP53SMN1; SMN2GAA
SCHEMBL17499237 0.79 ALDH1A1 (0.43) KMT2ANPC1RAB9AMEN1SMN1; SMN2
SCHEMBL16101347 0.79 TDP1 (0.31)
SCHEMBL16101305 0.79 RAB9A (0.37) KMT2ANPC1RAB9ASMN1; SMN2GAA
SCHEMBL17499239 0.79 RAB9A (0.46) KMT2ANPC1RAB9AMEN1TP53
SCHEMBL17499566 0.78 GAA (0.33) RAB9ASMN1; SMN2GAA
SCHEMBL16102259 0.77 HPGDS (0.32) GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2969593-B1 POLYMERS FUNCTIONALIZED WITH HETEROCYCLIC IMINES BRIDGESTONE CORP (JP) 2020-11-04 EP disclosed
US-9850328-B2 Polymers functionalized with heterocyclic imines BRIDGESTONE CORPORATION (JP) 2017-12-26 US disclosed
US-20160039958-A1 Polymers Functionalized With Heterocyclic Imines BRIDGESTONE CORPORATION (JP) 2016-02-11 US disclosed